If inhibition: From pure heart reduction to treatment of stable angina

European Heart Journal, Supplement

Volumn 7, Issue H, 2005, Pages

  Tendera, Michal ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; IVABRADINE; NITRIC ACID DERIVATIVE; VERAPAMIL;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLAUDICATION; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE EXACERBATION; DRUG SAFETY; EDITORIAL; ERECTILE DYSFUNCTION; EXERCISE TOLERANCE; FATIGUE; HEART MUSCLE CONTRACTILITY; HEART RATE; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; LETHARGY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS NODE; SINUS TACHYCARDIA; STABLE ANGINA PECTORIS;

EID: 24744433711     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui046     Document Type: Editorial

References (37)

1. Dyer AR, Persky V, Stamler J. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-749.
2. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study. Am Heart J 1991;121:172-177.
3. Kannel WB, Kannel C, Paffenberger RS et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494.
4. Mensink GBM, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997;18:1404-1410.
5. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30:1104-1106.
6. Diaz A, Bourassa MG, Guertin MC et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-974.
7. Andrews TC, Fenton T, Glasser SP et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. Circulation 1993;88:92-100.
8. Pratt CM, McMahon RP, Goldstein S et al. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia [the Asymptomatic Cardiac ischemia Pilot (ACIP) Study]. Am J Cardiol 1996;77:1302-1309.
9. Kop WJ, Verdino RJ, Gottdiener JS et al. Changes in heart rate and heart rate variability before ambulatory ischemic events. J Am Coll Cardiol 2001;38:742-749.
10. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-182.
11. Perski A, Hamstein A, Lindvall K et al. Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J 1988;116:1369-1373.
12. Sutton-Tyrrell K, Alcon HG, Wolfson SK Jr et al. Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Stroke 1993;24:355-361.
13. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001;104:1477-1482.
14. Aronow WS, Ahn C, Mercando AD et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996;78:1175-1176.
15. Shaper AG, Wannamethee G, Macfarlane PW et al. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993;70:49-55.
16. Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996;156:505-509.
17. Disegni E, Golbourt U, Reicher-Reiss H et al.; the SPRINT Study Group. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J Clin Epidemiol 1995;48:1197-1205.
18. Hjalmarson A, Gilpin EA, Kjekshus J et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65:547-553.
19. Zuanetti G, Hernandez-Bernal F, Rossi A et al. Relevance of heart rate as a prognostic factor in myocardial infarction: the GISSI experience. Eur Heart J Suppl 1999;1:H52-H57.
20. European Health for All Database. WHO Regional Office for Europe, Copenhagen, Denmark. www.euro.who.int/hfadb
21. Recommendations of the Task Force of the European Society of Cardiology. Management of stable angina pectoris. Eur Heart J 1997;18:394-413.
22. Brunelli C, Cristofani R, L'Abbate A. Long term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data. Eur Heart J 1989;10:292-303.
23. Dargie HJ, Ford I, Fox KM on behalf of the TIBET Investigators. Total Ischaemic Burden European Trial (TIBET). Eur Heart J 1997;17:104-112.
24. The Beta-Blocker Pooling Project Research Group. The Beta-blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. Eur Heart J 1988;9:8-16.
25. Brown HF, DiFrancesco D. Voltage-clamp investigations of membrane currents underlying pacemaker activity in rabbit sino-atrial node. J Physiol 1980;308:331-351.
26. Bois P, Bescond J, Renaudon B et al. Mode of action of bradycardic agent S 16257 on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996;118:1051-1057.
27. f channels by ivabradine. J Gen Physiol 2002;120:1-13.
28. Vilaine JP, Bidouard JP, Lesage L et al. Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. J Cardiovasc Pharmacol 2003;42:688-696.
29. Monnet X, Colin P, Ghaleh B et al. Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J 2004;5:579-586.
30. f inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817-823.
31. f current inhibitor ivabradine compared to atenolol as monotherapies in patients with chronic stable angina. A 4-month randomized, double-blinded, multicenter, controlled non-inferiority trial. Eur Heart J 2003;24(Suppl.):20.
32. f current inhibitor ivabradine compared to amlodipine as monotherapies in patients with chronic stable angina. Randomised, controlled, double-blind trial. Eur Heart J 2004;25(Suppl.):138.
33. Steg PG, Himbert, D. Unmet medical needs and therapeutic opportunities in stable angina. Eur Heart J 2005;7(Suppl H):H7-H15.
34. f inhibition: expected clinical benefit from pure heart rate reduction in coronary patients. Eur Heart J 2005;7(Suppl H):H16-H21.
35. f inhibition. Eur Heart J Suppl 2005;7(Suppl H):H29-H32.
36. f inhibition: therapeutic utility from clinical trials. Eur Heart J Suppl 2005;7(Suppl H):H22-H28.
37. f inhibition in various cardiac conditions. Eur Heart J Suppl 2005;7(Suppl H):H33-H36.